The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Running, not enrolling

Conditions studied: Frailty, Sarcopenia, COVID-19

In brief

Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decreased patient strength and vitality.

Key facts

Study ID

NCT05935800

Run by

Methodist Health System

People needed

208

Starts

2022-04-19

Expected to finish

2028-04-19

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years and older Underwent pre-transplant frailty assessment (PFA) at MDMC

You may not qualify if…

• Not a patient at Liver Institute at Methodist Dallas

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.